Material Information - Announcement of the U.S. FDA’s Positive Preliminary Comments on the Filing for Expansion of Indication of BESREMi for Essential Thrombocythemia (ET)

Download Material Information - Announcement of the U.S. FDA’s Positive Preliminary Comments on the Filing for Expansion of Indication of BESREMi for Essential Thrombocythemia (ET) Previous Next

The release as fetched from its publisher. pharmaessentia.com ↗